🔗 Share this article

As the United States proceeds with sweeping revisions to its vaccination recommendations, a particular individual has surfaced unexpectedly: Dr. Tracy Beth Høeg, a US-based sports physician and epidemiologist who rose to prominence by questioning COVID-19 vaccinations during the global health crisis and has focused upon potential fatalities following Covid immunization in her brief tenure at the Food and Drug Administration.

Scheduled Changes to Childhood Immunization Schedule

Public health authorities planned to unveil major changes to the pediatric immunization program in December, bringing the US with Denmark’s national calendar, according to reports – a significant shift that would place the US out of step with much of the world with no evidence for public health gain. The announcement has been postponed until the next year.

Rather than the director of the vaccine center, Dr. Høeg is scheduled to address the audience at the event. She was recently named interim head of the FDA’s CDER, the fifth person to lead the division this year.

A New Direction at the Regulatory Body

The acting appointment could signify a strengthened alliance between the pharmaceutical and vaccine centers as Dr. Høeg and Prasad solidify control at the agency – and it signals a renewed priority upon rolling back already-approved immunizations at the FDA.

Høeg has often pushed for ending certain childhood shot schedules in the US so as to align more in line with Denmark's approach, a society with nationalized medicine and a population about the size of Wisconsin’s.

To date public appearances, she has continued to focus on vaccination policy – usually the responsibility of Prasad, head of the FDA’s vaccine center – instead of pharmaceutical oversight.

Questions Over Qualifications

The appointee has little discernible track record in drug development, approval processes or management, which has been customary for previous heads of the biologics center. She has been employed at the FDA as a senior adviser to the agency head and the vaccine center since March.

“She appears not to have any of the qualifications” for overseeing the pharmaceutical oversight division, said Dr. Jonathan Howard. “She has not conducted a randomized controlled trial. She lacks experience in running a large organization. She has no expertise in drug approvals.”

Previous directors of the center would “understand laws and regulations and the research of drug development”, said a former acting FDA commissioner. “Frankly, she has not acquired the type of experience that prior appointees who ran the center have had.”

This division has an enormous portfolio at the agency, Woodcock emphasized.

“The public just zeroes in on the novel medication approvals, but the generic program clears thousands of generic drugs. There is also a biosimilars program, OTC medication office and more, and all of those must be supervised,” Dr. Woodcock explained. “The thing you neglect, that is precisely what that I always told people is going to cause problems.”

There is also, a substantial leadership component to the role, which manages in excess of 5,000 staff members. “It is a huge management job, if you do it right,” she said.

Official Statement and Controversial Policies

When asked about inquiries about Høeg’s credentials and whether this selection represents greater collaboration among regulatory chiefs on immunizations, a representative responded that the “inquiries stem from flawed assumptions”.

“This background aligns with the functions of her role,” the official stated, citing the time Høeg spent advising the agency head on “drug safety and approval science, including computational safety modeling and vaccine surveillance”.

As acting director, Høeg takes over the commissioner’s recently launched fast-track approval initiative, a disputed expedited therapy clearance system that apparently troubled her preceding directors. “How are these therapies being picked for this fast-track system? Who takes the calls?” Dr. Howard questioned. “There’s a lot of secrecy happening at the regulatory body right now.”

Overall, he stated, “the Food and Drug Administration seems to be moving towards laxer rules of pharmaceuticals, except for immunizations.”

Documented History on Vaccines

Regarding vaccines, Dr. Høeg has a more established, if concerning, history, critics have noted. She published a study using unconfirmed volunteer-provided data to assess the frequency of heart inflammation after COVID-19 vaccination. She advised the state of Florida chief medical officer Joseph Ladapo, who allegedly have changed statistics to indicate COVID-19 vaccines are riskier than they are.

Included in her “policy goals” for the current administration featured revising regulations for new vaccines and discontinuing “optional” immunizations, she said following the vote on a podcast. At the agency, Dr. Høeg has allegedly proposed preventing young men from obtaining COVID-19 vaccines.

“She’s an all-around true believer who starts off with her preconceived notions and tailors the evidence to fit the data in a highly deceptive, untruthful fashion,” Dr. Howard stated.

Consolidating Power and a “Push for Payback”

Høeg joined fellow skeptics, {like|